Clinical Features of Polycythemia Vera and Essential Thrombocythemia in Japan: Retrospective Analysis of a Nationwide Survey by the Japanese Elderly Leukemia and Lymphoma Study Group-Reference-Cited by-同舟云学术

Clinical Features of Polycythemia Vera and Essential Thrombocythemia in Japan: Retrospective Analysis of a Nationwide Survey by the Japanese Elderly Leukemia and Lymphoma Study Group

Published:2006-06-01 Issue:5 Volume:83 Page:443-449
ISSN:0925-5710
Container-title:International Journal of Hematology
language:
Short-container-title:International Journal of Hematology

Author:

Dan Kazuo,Yamada Takashi,Kimura Yukihiko,Usui Noriko,Okamoto Shinichirou,Sugihara Takashi,Takai Kazue,Masuda Michihiko,Mori Mayumi

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://www.springerlink.com/index/pdf/10.1532/IJH97.06009

Reference28 articles.

1. Pierre R, Imbert M, Thiele J, Vardiman JW, Brunning RD, Flandrin G. Polycythemia vera. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds.World Health Organization Classification of Tumours. Pathology and Genetics: Tumours of Hematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001: 32-34.

2. Imbert M, Pierre R, Thiele J, Vardiman JW, Brunning RD, Flandrin G. Essential thrombocythemia. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, edsWorld Health Organization Classification of Tumours. Pathology and Genetics: Tumours of Hematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001: 39-41.

3. Fialkow PJ, Faguet GB, Jacobson RJ, Vaidya K, Murphy S. Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell. Blood. 1981;58:916-919.

4. Adamson JW, Fialkow PJ, Murphy S, Prchal JF, Steinmann L. Polycythemia vera: stem-cell and probable clonal origin of the disease. N Engl J Med. 1976;295:913-916.

5. Kippel S, Strunck E, Busse CE, Behringer D, Pahl HL. Biochemical characterization of PRV-1, a novel hematopoietic cell surface receptor, which is overexpressed in polycythemia rubra vera. Blood. 2002;100:2441-2448.

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world patient characteristics and treatment patterns of polycythemia vera in Taiwan between 2016 and 2017: a nationwide cross-sectional study;Therapeutic Advances in Hematology;2023-01

2. IV．骨髄増殖性腫瘍の初期診断と外来治療;Nihon Naika Gakkai Zasshi;2022-07-10

3. Clinical characteristics of Japanese patients with polycythemia vera: results of the JSH-MPN-R18 study;International Journal of Hematology;2022-07-09

4. Efficacy and safety of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: an open-label, single-arm, phase 2 study;International Journal of Hematology;2022-04-16

5. Myelofibrotic and leukemic transformation in 2016 WHO-defined Philadelphia-negative myeloproliferative neoplasm;Blood Research;2022-03-31